Euro Heart Congress 2020: A skeptical and detailed analysis on the trends of market
Euro Heart Congress 2020 invites each and every individual who are wondering about the acute possible functionalities and rhythm of heart to attend the “8th World Heart Congress” which will be held on May 11-12, 2020 at the city of beautiful architecture, fine culture and famous as Bavarian capital, Munich, Germany where one can discuss and present brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops, Speaker sessions.
Euro Heart Congress is an International conference which attracts the global speakers such as world-class professors, scientists, researchers, students, Perfusionists, cardiologists with the Theme: “Divulging into the functionalities and acute insights of Heart”, and is designed for professionals at all levels and career phases, who want to improve their understanding of what will drive and shape the future of the cardiovascular market. This conference will be focused on methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, Pediatric Cardiology and health disorders. The strength of the Conference is that the participants tend to include from all phases of the value chain as well as individuals from a wide variety of sector and countries.
Why to attend???
- Build your professional network.
- Hear about the latest research.
- Improve your presentation and communication skills.
- Get response on an early version of your latest work.
- Acquire beyond your field or interest.
- Get opportunity to people to meet you.
- Know the strengths and weakness of your conferences.
- Easier to solve the problems and struggles which you go through at work.
Target Audience:
- Scientists
- Young research fellows
- Research Scholars
- Residents, Fellows & Post Docs
- Students
- Cardiovascular device marketers, Pharma Companies
- Business Executives & Directors
- Cardiology Associations
- Advertising Agency Executives
- Industry professionals
Cardiology & Cardiovascular Devices Growth: Global Market Research Report:
The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and should reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022. The cardiovascular surgical devices measured are interventional cardiology devices like stents, angioplasty balloons, catheters and accessories, guide wires, cannulae, and valves; cardiac rhythm management devices like implantable cardiac defibrillators (ICD), pacemakers and leads; cardiac assist devices (CAD) like ventricular assist devices, cardiac resynchronization therapy (CRT) devices, intra-aortic balloon pump, total artificial heart; and other vascular surgery devices like endovascular grafts, IVC filters and occlusion devices. The major cause of death across the globe is the cardiovascular diseases. It accounted for 17.3 million deaths in 2015 and is further anticipated to claim 23.6 million lives in 2030 (according to estimation by the World Health Organization). The International Diabetes Federation has projected that approx. 415 million people were diabetic in 2015 and is expected rise to 642 million worldwide by 2040. By 2020, the global spending on diseases such as cardiovascular diseases, cancer, and respiratory diseases is expected to reach $4 trillion. The global interventional cardiology market was projected at $14.69 billion in 2017 and is anticipated to reach $24.96 billion by 2027.
Based on the (CRM) devices market analysis, this market will grow at a CAGR of almost 8% by 2021. The adoption rate of congestive heart failure drugs market will grow at a CAGR of more than 10% by 2022. The systemic hypertension drugs market is anticipated to reach more than USD 27 billion by the end of 2020. The global hypertension drugs market is predicted to have a remarkable market value of USD 32 billion by the end of 2020. According to the angina pectoris drugs market analysis, the market analysts estimate that the market will grow steadily at a CAGR of about 4% by 2021. The cardiac prosthetic devices industry analysis, this market will grow steadily at a CAGR of almost 14% by 2021. Overview of the global cardiac monitoring market shows that it will grow steadily at a CAGR of more than 8% by 2021. The global cardiovascular training equipment market will grow steadily at a CAGR of more than 4% over the forecast period of 2016-2022. The global POC cardiovascular diagnostic market is estimated to reach over USD 1.3 billion by 2022. Global Cardiovascular Information System market will grow at a CAGR of 7.90 per cent over the period 2019-2023.
In the all-over global market, North America is the leading contributor to the global interventional cardiology market. The Asia-Pacific is expected to grow at a CAGR of 7.12% in the forecast period 2018-2027. The global interventional cardiology market for innovative devices is majorly dominated by United Stated followed by the European players.
Name: Sarah Bruce
Contact Number: +44 2039363178
Email: heartcongress@europemeet.com